Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathy
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2023.1098184
Abstract: Introduction: The endothelial glycocalyx degrading enzyme heparanase-1 (HPSE1) is a major contributor to kidney diseases, such as glomerulonephritis and diabetic nephropathy. Therefore, inhibition of HPSE1 could be an interesting therapeutic strategy to treat glomerular diseases.… read more here.
Keywords: hpse2; glomerulonephritis diabetic; heparanase; hpse1 ... See more keywords